Major Medical Devices
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Major Medical Devices firmographics
Firmographics- Name
- Major Medical Devices
- Legal name
- Major Medical Devices, Inc.
- Website
- https://majormedicaldevices.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Major Medical Devices industry classification
Industry- Product category
- Vascular Medical Devices (Endovascular Stent-Grafts)
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)
Keywords
Where Major Medical Devices is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
Major Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Major Medical Devices is an emerging innovator in vascular intervention technologies developing the AxSES™ device for AAA repair. As a medical device company, revenue will be generated through sales of its proprietary stent-graft device and delivery system. The company is moving toward market entry with a $3 billion market opportunity in the AAA repair space.
Go-to-market motion1 record
Marketing channels4 records
Major Medical Devices product offering
Product offeringCore offering
Major Medical Devices develops the AxSES™ ultra-low-profile stent-graft system for endovascular abdominal aortic aneurysm (AAA) repair. The device combines an ultra-low-profile stent graft with a delivery system engineered for single-site, upper extremity access, enabling antegrade delivery from a single arterial puncture above the diaphragm and eliminating the need for bilateral femoral access. The product targets patients currently excluded from standard EVAR due to small, calcified, or diseased vessels.
Product overview
Major Medical Devices is a single-product focused medical device company developing the AxSES™ ultra-low-profile stent-graft system for abdominal aortic aneurysm (AAA) repair. The product combines a low-profile stent graft with a delivery system engineered for single-site upper extremity (arm/shoulder) access, enabling antegrade delivery aligned with natural blood flow and eliminating the need for traditional bilateral femoral access. This approach targets patients with small or calcified vessels who are typically excluded from standard EVAR procedures.
Differentiator
Problem solved
Functional benefit
Brands
- AxSES™: Ultra-low-profile stent-graft device designed for single-site, upper extremity access AAA repair, enabling patients with small or calcified vessels to undergo EVAR treatment.
Products and services
- AxSES™ AxSES™ is an ultra-low-profile stent-graft system designed for endovascular abdominal aortic aneurysm (AAA) repair. It combines an ultra-low-profile stent graft with a delivery system engineered for single-site, upper extremity (arm/shoulder) arterial access, enabling antegrade delivery aligned with natural blood flow. The device targets patients with small or calcified vessels, female patients, Asian patients with smaller vessel diameters, patients with complex aneurysm anatomy, and patients with femoral access concerns who are currently excluded from standard EVAR.
Quantifiable outcome
- 86% of vascular surgeons believe there is high unmet clinical need for this patient population (female, Asian patients with smaller vessels, complex anatomy, femoral access concerns)
- +3 more outcomes
Companies that use Major Medical Devices
Customer profileSegments2 records
Ideal customer profiles1 record
Major Medical Devices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Major Medical Devices partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Major Medical Devices competitors and assessment
Company assessmentDirect peers
- Endologix: Endologix markets the AFX and Ovation Alto stent graft systems, the latter being a direct ultra-low-profile competitor in the same AAA repair space. Most notably, Dr. Andrew Kerr, co-founder of Major Medical Devices, previously co-invented TriVascular, which was acquired by Endologix, making Endologix the closest historical and product analog.
- Cook Medical: Cook Medical manufactures the Zenith AAA Endograft and related low-profile variants for endovascular AAA repair, competing directly with AxSES™ in the same surgical setting. Its Zenith line has long-standing vascular surgeon relationships and serves as a benchmark for procedural workflow in standard EVAR.
- W.L. Gore & Associates (Gore Medical): Gore Medical is the dominant incumbent in endovascular AAA repair with the Excluder AAA Endoprosthesis and the Conformable Excluder, sold to the same vascular surgeon customers Major Medical Devices targets. The company represents both the primary competitive threat and the benchmark Major Medical Devices must displace on upper-extremity access.
- Lombard Medical Technologies: Lombard Medical manufactures the Aorfix and Altura AAA endograft systems, including low-profile configurations. It is a direct EVAR peer with overlapping patient indications and vascular surgeon customers, and represents a comparable mid-stage commercial scale.
- Artivion (formerly CryoLife / Jotec): Artivion markets Jotec aortic stent grafts (E-tegra, E-vita) for abdominal and thoracic aortic repair. It is a direct competitor in the endovascular AAA space, particularly in Europe, and serves overlapping vascular surgery customers.
- Terumo (Bolton Medical): Terumo acquired Bolton Medical and sells the Treovance and RelayPro stent graft systems for AAA and thoracic aortic repair. The company directly competes in the aortic endograft category and represents a global commercial threat to AxSES™ in international markets.
Broad incumbents
- Medtronic: Medtronic sells the Endurant and Valiant stent graft systems for AAA and thoracic aortic repair, and operates as a broad incumbent across vascular surgery. It serves the same vascular surgeon customer base and has the R&D scale to iterate on low-profile and alternative-access approaches.
Emerging players
- Penumbra: Penumbra is a vascular-focused medical device company with peripheral and aortic-adjacent technologies (e.g., Lightning Bolt, Indigo systems). While not a direct AAA stent-graft competitor, it operates in the same endovascular surgery channels and represents an emerging player with overlapping customer relationships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Major Medical Devices social profiles
Digital presenceMajor Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Major Medical Devices leadership team
Management profileNumber of profiles
Profiles6 records
Major Medical Devices funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Major Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Major Medical Devices
What does Major Medical Devices do?
Major Medical Devices develops the AxSES™ ultra-low-profile stent-graft system for endovascular abdominal aortic aneurysm (AAA) repair. The device combines an ultra-low-profile stent graft with a delivery system engineered for single-site, upper extremity access, enabling antegrade delivery from a single arterial puncture above the diaphragm and eliminating the need for bilateral femoral access. The product targets patients currently excluded from standard EVAR due to small, calcified, or diseased vessels.
Is Major Medical Devices a public or private company?
Major Medical Devices is a private company. It is classified as venture growth investor backed and is currently operating.
When was Major Medical Devices founded?
Major Medical Devices was founded in 2019. It employs 1 to 10 people.
Where is Major Medical Devices based?
Major Medical Devices is headquartered in New York, United States, in the North America region.
How does Major Medical Devices make money?
One revenue line is on record: medical Device Sales.
Who are Major Medical Devices's main competitors?
Direct peers on record are Endologix, Cook Medical, W.L. Gore & Associates (Gore Medical), Lombard Medical Technologies, Artivion (formerly CryoLife / Jotec) and Terumo (Bolton Medical). Medtronic is listed as a broad incumbent. Penumbra is listed as an emerging player.
Does Major Medical Devices have an API?
No public API is recorded for Major Medical Devices.
What industry is Major Medical Devices in?
Major Medical Devices's product category is Vascular Medical Devices (Endovascular Stent-Grafts). Its primary akta.pro industry code is HLAHAFAF, Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts. Its NAICS code is 339112 and its SIC code is 3841.